Neutrophilic inflammation in the respiratory mucosa predisposes to RSV infection
The variable outcome of viral exposure is only partially explained by known factors. We administered respiratory syncytial virus (RSV) to 58 volunteers, of whom 57% became infected.
|
7th Influenza Conference 2020
Influenza in persons living with diabetes: Pathogenesis and prevention
Satellite Symposium by the IDC/supported by Sanofi Pasteur
Video
Partner Organisations
|
7th Influenza Conference 2020
Should we introduce national live vaccination programmes for children?
ESPID/ESWI joint symposium supported by AZ
Reports
Policy & Recommendations
News
|
8th influenza conference 2021
ESWI 2021 Conference Science Policy Interface highlights
A report summarising the Science Policy Interface Track
Vaccination in a COVID-19 era
First webinar in the series: Preparing for COVID-19, RSV disease and Inlfuenza concomitant outbreaks, chaired by Ab Osterhaus and Sylvie ...
Childhood Influenza Vaccination and treatment in a COVID-19 era
Second webinar in the series: Preparing for COVID-19, RSV disease and Inlfuenza concomitant outbreaks, chaired by Ab Osterhaus and George...
COVID-19 Treatment and Medication
Third webinar in the series: Preparing for COVID-19, RSV disease and Inlfuenza concomitant outbreaks, chaired by Ab Osterhaus and Marco G...
RSV Disease in a COVID-19 era
Fourth webinar in the series: Preparing for COVID-19, RSV disease and Inlfuenza concomitant outbreaks, chaired by Ab Osterhaus and Peter ...
Flu & Chronic Health Conditions Toolkit
The National Foundation for Infectious Diseases (NFID) has developed the following downloadable resources for Healthcare professionals (H...
What about respiratory virus infections? Prevention for people living with diabetes in Covid times
Flu and COVID-19 booster Vaccinations: where do we go?
Fifth webinar in the series: Preparing for COVID-19, RSV disease and Inlfuenza concomitant outbreaks, chaired by Rebecca Cox
|
8th influenza conference 2021
8th ESWI Influenza Conference